GIORDANO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 21.570
EU - Europa 9.186
AS - Asia 3.500
AF - Africa 151
SA - Sud America 50
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 34.491
Nazione #
US - Stati Uniti d'America 21.515
IT - Italia 3.466
CN - Cina 2.028
FI - Finlandia 1.508
UA - Ucraina 1.054
SG - Singapore 972
IE - Irlanda 749
DE - Germania 720
GB - Regno Unito 438
SE - Svezia 278
RU - Federazione Russa 244
FR - Francia 208
CI - Costa d'Avorio 134
KR - Corea 130
BE - Belgio 115
RO - Romania 105
IN - India 102
TR - Turchia 93
PL - Polonia 67
NL - Olanda 59
IR - Iran 42
CH - Svizzera 36
CA - Canada 31
CZ - Repubblica Ceca 27
HK - Hong Kong 27
ES - Italia 26
BR - Brasile 22
AT - Austria 21
GR - Grecia 20
MX - Messico 19
TW - Taiwan 19
JP - Giappone 14
AU - Australia 13
UZ - Uzbekistan 13
EG - Egitto 10
CL - Cile 9
DK - Danimarca 9
EU - Europa 9
IQ - Iraq 9
PK - Pakistan 9
BG - Bulgaria 8
CO - Colombia 8
ID - Indonesia 7
LB - Libano 7
NZ - Nuova Zelanda 7
PE - Perù 6
A2 - ???statistics.table.value.countryCode.A2??? 5
IL - Israele 5
PT - Portogallo 4
TH - Thailandia 4
HR - Croazia 3
LT - Lituania 3
NO - Norvegia 3
RS - Serbia 3
VN - Vietnam 3
AL - Albania 2
AR - Argentina 2
BD - Bangladesh 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
KH - Cambogia 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
ET - Etiopia 1
GH - Ghana 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
PA - Panama 1
QA - Qatar 1
SM - San Marino 1
SV - El Salvador 1
Totale 34.491
Città #
Fairfield 3.029
Ashburn 1.972
Chandler 1.632
Woodbridge 1.608
Houston 1.495
Wilmington 1.386
Seattle 1.182
Ann Arbor 1.139
Cambridge 1.015
Singapore 759
Dublin 745
Palermo 703
Jacksonville 609
Medford 584
Des Moines 426
Nanjing 386
Princeton 375
Altamura 253
Boardman 232
Dearborn 224
New York 202
Lawrence 187
Tulsa 187
San Diego 185
Beijing 164
Shenyang 144
Changsha 138
Nanchang 138
Santa Clara 136
Abidjan 134
Jinan 134
Hebei 124
Milan 114
Brussels 111
Jiaxing 98
Rome 93
Seongnam 92
Tianjin 92
Ludwigshafen am Rhein 91
Ningbo 88
London 84
Izmir 81
Phoenix 72
Venice 71
Saint Petersburg 66
Atlanta 63
Zhengzhou 61
Frankfurt 58
Falls Church 57
Guangzhou 55
Redwood City 55
Kumar 53
Hangzhou 50
Munich 46
San Paolo di Civitate 42
Verona 41
Helsinki 36
Taizhou 36
Columbus 34
Washington 34
Haikou 33
Orange 33
Auburn Hills 32
Los Angeles 30
Taiyuan 30
Bremen 28
Tehran 27
Bucheon-si 26
Chicago 26
Napoli 24
Norwalk 23
Polska 23
Naples 22
Dallas 21
Lanzhou 21
Pune 21
Brno 20
Durham 20
Kunming 18
Bologna 17
Catania 17
Düsseldorf 16
Fuzhou 16
Hefei 16
Amsterdam 15
Edinburgh 15
Redmond 14
Taipei 14
Central 13
Florence 13
Kilburn 13
Moscow 13
Bari 12
Piscataway 12
Den Haag 11
Foggia 11
Hounslow 11
Pisa 11
Messina 10
Ottawa 10
Totale 24.259
Nome #
The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium 325
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 314
Valutazione dell’insulino-sensibilità tramite clamp euglicemico iperinsulinemico in bambini in terapia sostitutiva con GH. 275
Mesenchymal stem cells derived from inflamed dental pulpal and gingival tissue: a potential application for bone formation 243
Epigenetic Involvement in Hutchinson-Gilford Progeria Syndrome: A Mini-Review 236
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 219
In vitro generation of pancreatic endocrine cells from human adult fibroblast-like limbal stem cells 197
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 195
Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cells 188
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. 188
Knockdown of NANOG Reduces Cell Proliferation and Induces G0/G1 Cell Cycle Arrest in Human Adipose Stem Cells 187
Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study 186
Dual drug-loaded halloysite hybrid-based glycocluster for sustained release of hydrophobic molecules 183
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 182
Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis. 180
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 179
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 177
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 177
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 176
Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto’s thyroiditis 175
(Dipyrido[3,2-a:2',3'-c]phenazine)(glycinato)copper(II) perchlorate: A novel DNA-intercalator with anti-proliferative activity against thyroid cancer cell lines 174
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 173
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 173
MULTIPLE PLURIPOTENT STEM CELL MARKERS IN HUMAN ANAPLASTIC THYROID CANCER: THE PUTATIVE UPSTREAM ROLE OF SOX-2 171
Early Lung Function Abnormalities in Acromegaly. 170
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 169
Identification of Novel Wsf1 Mutations in a Sicilian Child with Wolfram Syndrome 166
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency 166
Factors associated with circulating concentrations of irisin in the general population cohort of the ABCD study 165
Hepatic steatosis index in acromegaly: Correlation with insulin resistance regardless of the disease control 165
GHD come predittore di sindrome metabolica 164
Dental pulp stem cells for bone tissue engineering: a review of the current literature and a look to the future 164
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 163
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes 163
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 161
Hutchinson Gilford Progeria Syndrome: A Therapeutic Approach via Adenoviral Delivery of CRISPR/cas Genome Editing System 160
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index 160
Multicavity halloysite-amphiphilic cyclodextrin hybrids for co-delivery of natural drugs into thyroid cancer cells 160
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study 159
Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment 159
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 158
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 158
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS 158
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency 158
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 156
CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children 156
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 154
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. 154
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 153
Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency 152
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 151
A ceRNA analysis on LMNA gene focusing on the Hutchinson-Gilford progeria syndrome 151
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 149
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 149
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 147
The Metabolic Profile in Active Acromegaly is Gender-Specific. 147
Association of obesity and diabetes with thyroid nodules 146
Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines. 145
Ambulatory Glucose Profile Applied to Flash Glucose Monitoring in Real Life: An Expert Opinion. 143
Physical activity and cardiovascular prevention: Is healthy urban living a possible reality or utopia? 143
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. 141
Differente pattern di espressione di citochine a fenotipo Th1 e Th2 nei pazienti affetti da diabete di tipo 1 (T1DM) e con associata tireopatia autoimmune (AITD) 140
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy 140
Anti-Inflammatory Action of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Patients with Autoimmune Endocrine Disorders 140
Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. 139
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 139
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 139
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction 138
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study. 138
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 137
Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial. 137
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 137
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS 137
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 136
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 136
Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children 136
The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency 136
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment 135
Corneal thickness in children with growth hormone deficiency: The effect of GH treatment. 134
Characterization of metabolically healthy obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD Study 134
Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis 134
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. 132
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study. 132
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 131
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study 131
Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives 129
L'ERNIAZIONE DELLE GHIANDOLE LACRIMALI IN PAZIENTI CON OFTALMOPATIA DI GRAVES: UN POSSIBILE MARKER DI ATTIVITÀ DELLA MALATTIA. 129
Production of a double layer scaffold for the “on demand” release of fibroblast-like limbal stem cells 128
Different Th1/Th2 cytokine expression in Type 1 diabetes mellitus patients (T1DM) alone or associated with autoimmune thyroid disease (AITD) 126
Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess 126
Diabete e complicanze materno-fetali in gravidanza: confronto tra pazienti con diabete tipo 1 e tipo 2 pregravidico. 126
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report 126
Human exfoliated deciduous teeth and oral mucosa: promising applications in tissue regeneration 126
Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency 126
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 125
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 124
Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome 124
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency. 122
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours. 122
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 122
Totale 15.805
Categoria #
all - tutte 134.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.869 0 0 0 0 928 1.123 808 563 820 421 885 321
2020/20214.562 274 333 385 364 343 201 465 337 543 399 422 496
2021/20224.357 145 802 136 180 251 186 179 235 509 574 289 871
2022/20235.133 559 818 87 526 574 824 356 373 643 57 222 94
2023/20242.576 106 404 123 257 240 582 241 149 43 79 45 307
2024/20251.861 241 362 495 612 151 0 0 0 0 0 0 0
Totale 36.574